GH

Guardant Health

NASDAQ

31.48

+0.41

+1.30%

Closed 16:07 01/27 EST

OPEN

30.74

PREV CLOSE

31.07

HIGH

31.88

LOW

30.59

VOLUME

1.00M

TURNOVER

52 WEEK HIGH

78.34

52 WEEK LOW

24.63

MARKET CAP

3.22B

P/E (TTM)

-5.3027

ClearBridge Multi Cap Growth Strategy Q4 2022 Portfolio Manager Commentary

Seeking Alpha · 5d ago

ClearBridge Aggressive Growth Strategy Q4 2022 Portfolio Manager Commentary

Seeking Alpha · 01/22 04:15

Guardant Health: Positive ECLIPSE Data Signals More Upside

Seeking Alpha · 01/20 13:25

Guardant Health And The Royal Marsden NHS Foundation Trust Partner On Highly Anticipated TRACC Part C Trial To Use Guardant Reveal Blood Test To Help Guide Treatment Decisions In Colorectal Cancer

Benzinga · 01/19 13:07

Invitae: What Happened At The JP Morgan Health Conference

Seeking Alpha · 01/19 11:41

Natera, Myriad upgraded as Raymond James reviews genetic testing space

Seeking Alpha · 01/18 14:58

Guardant Health To Showcase New Data At Asco Gi 2023 Demonstrating Utility Of Its Blood Tests For Patients With Gastrointestinal Cancers

Benzinga · 01/17 21:12

Cathie Wood Makes This Molecular Diagnostics Company Top Holding Of Ark Invest's Flagship Fund, Catapulting Past Zoom, Tesla

Benzinga · 01/11 16:19

About GH

Guardant Health, Inc. is a precision oncology company. The Company is focused on helping conquer cancer through the use of its blood-based tests, data sets, and advanced analytics. It has developed its Guardant360, Guardant360 CDx, and GuardantOMNI liquid biopsy-based tests for advanced-stage cancer. It also developed its Guardant Reveal liquid biopsy-based test for residual and recurring cancer to address the need for Stage II-II I colorectal cancer. Its Guardant360 test is a molecular diagnostic test measuring 74 cancer-related genes. Its Guardant360 CDx test is a liquid biopsy test measuring 55 cancer-related genes. Its GuardantOMNI test has a broader 500-gene panel, all of which analyze circulating tumor deoxyribonucleic acid (DNA) in the blood. The Company's tests are used by biopharmaceutical companies for a range of applications, including identifying patient populations to accelerate translational science research and clinical trial enrollment, and companion diagnostic.

Webull offers kinds of Guardant Health Inc stock information, including NASDAQ:GH real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, GH stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading GH stock methods without spending real money on the virtual paper trading platform.